DOPC Liposomal Formulation of Antimicrobial Peptide LL17-32 with Reduced Cytotoxicity: A Promising Carrier Against <i>Porphyromonas gingivalis</i>
<b>Background/Objectives:</b> The rapid emergence of antibiotic-resistant oral pathogens has rendered many conventional therapies increasingly ineffective. Antimicrobial peptides (AMPs) have emerged as a promising therapeutic alternative due to their unique mechanisms of action and low propensity fo...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2025-11-01
|
| סדרה: | Pharmaceutics |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1999-4923/17/11/1424 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
